Add Row
Add Element
cropper
update
National Cannabis Newswire
update
Add Element
  • Home
  • Categories
    • news
    • trends
    • insights
    • industry
    • legalization
    • health
    • culture
    • advocacy
    • Brands
    • New Mexico Dispensaries
    • Arizona Dispensaries
December 25.2025
2 Minutes Read

Teen Marijuana Use Falls to Historic Lows as Legalization Expands

Teens enjoying outdoors, teen marijuana use decline context

The Surprising Decline in Teen Marijuana Use

As the landscape of cannabis legalization continues to evolve in the United States, astonishing data reveals a major shift in teen marijuana use. A federally funded survey by the University of Michigan has uncovered a significant trend since 2012: the percentage of teens experimenting with marijuana has been in a downward spiral. With recreational marijuana now legal in 24 states and the District of Columbia, one might expect teen use to rise. However, the opposite is true. Notably, between 2012 and 2025, lifetime cannabis use fell 23% among 12th graders, 35% among 10th graders, and 17% among 8th graders.

Debunking the Myths About Legalization

Concerns over legalized marijuana contributing to increased adolescent usage have been widespread. Many feared that easing restrictions would lead to easier access for minors and normalize use. Yet, evidence consistently contradicts this anxiety. Key insights from studies published in the *Journal of the American Medical Association* show no significant association between the legalization of recreational marijuana and an increase in adolescent usage rates. Instead, it has led to almost universal declines in youth consumption across many states, affirming the argument that regulation actually protects young people.

Understanding the Data: Year-by-Year Insights

The most recent survey findings bolster this narrative. Specifically, between 2024 and 2025, the reported past-month cannabis use dropped by 25% among 8th graders, with past-year consumption declining by 16%. Not only does this indicate that fewer teens are using cannabis, but it also reflects changing societal norms. As Dr. Nora Volkow, NIDA’s Director, points out, these trends highlight the need for ongoing observation to encourage healthy choices among youth.

The Role of Regulation in Protecting Youth

Regulatory frameworks accompanying legalization have ushered in a new era where access to marijuana is rigorously controlled. Strong age verification processes at dispensaries ensure minors cannot readily obtain marijuana. Furthermore, legal markets have significantly curtailed the illicit trade of cannabis, a primary source for underage users. It turns out that when marijuana is regulated, it is not only safer for adults but also less accessible to young people.

Fostering Healthy Discussion Through Education

Another contributing factor to this fascinating decline is the focus on education and awareness campaigns regarding the risks of marijuana use, particularly among developing adolescents. By normalizing the conversation about cannabis and equipping teens with knowledge, the charm of rebellion surrounding substance use may be wearing off. The more factual information teens have about cannabis, the less appealing they find it.

Conclusion: A New Era for Cannabis and Youth Health

The continuing decline in teen marijuana use amidst the legalization of cannabis for adults offers valuable insights for both lawmakers and society. The data overwhelmingly indicates that regulating cannabis does not equate to increasing youth usage rates. As states navigate this evolving landscape, it’s vital that they prioritize education and health initiatives to maintain this encouraging trend. For cannabis legalization enthusiasts, this offers hope: legalization not only facilitates access for adults but also safeguards youth health.

advocacy

0 Views

0 Comments

Write A Comment

*
*
Related Posts All Posts

How the US Executive Order on Medical Cannabis Impacts Ghana's Future in the Cannabis Industry

Update The Growing Global Acceptance of Cannabis The decision by President Trump to expand medical cannabis research in the United States marks a historic moment not just for America but for the global cannabis community. As the Chamber of Cannabis Industry Ghana (CannaCham) warmly welcomes this executive action, it signifies a deeper acceptance of cannabis for legitimate medical use worldwide. This move underlines the importance of grounded, evidence-based regulations surrounding cannabis and its derivatives, setting a precedent that resonates even in nations like Ghana, which is actively working on its own cannabis framework. CannaCham's Perspective on US Executive Actions CannaCham views the US executive order to expedite rescheduling marijuana from Schedule I to Schedule III of the Controlled Substances Act as a beacon of hope. CannaCham's officials expressed that this action sends a clear signal to countries looking to create a responsible cannabis industry. They believe Ghana stands on the cusp of a transformative moment where global best practices can inform local regulations and industry standards. Such proactive governmental revisions could open doors for economic growth through potential value-added exports and job creation in the Ghanaian cannabis sector. Implications for Cannabis in Ghana The implications of the recent US actions extend well beyond its borders. As Ghana aspires to carve out its place within the global cannabis market, CannaCham emphasizes the need for rigorous collaboration with research institutions and private sectors. This collaboration will enable Ghana to enhance regulatory standards and support responsible engagement across the entire cannabis value chain. Such steps, according to CannaCham, will not only improve Ghana's competitiveness internationally but also build a sustainable domestic market. The Challenge of Balancing Regulation and Opportunity As Ghana charts its path forward, the challenge lies in balancing regulatory oversight with market opportunities. CannaCham advocates for a public health-oriented approach that prioritizes scientific research and compliance with international standards. This perspective is crucial, especially in an industry that has often faced skepticism. Establishing a framework that caters to public health while fostering industry growth will be key to gaining both local and international trust. Engaging Stakeholders in the Cannabis Movement CannaCham encourages collaborative discussions among stakeholders, including government regulators, policymakers, and the cannabis industry. Engagement is essential to ensuring that Ghana learns from the experiences of other nations while establishing its standards. By aligning with global trends in cannabis regulation, Ghana can leverage international expertise and potentially participate in lucrative markets while maintaining stringent oversight over its own practices. Conclusion: Positioning Ghana for the Future of Cannabis The recent executive actions taken in the US reflect a broader trend of acceptance and research into the benefits of cannabis, offering valuable lessons for Ghana. As CannaCham leads the charge for sensible cannabis regulations in Ghana, the nation stands ready to adapt and grow alongside this evolving global landscape. Those involved in advocacy or the cannabis industry should take note: Ghana has a remarkable opportunity to become a leader in the cannabis sector in Africa, given the right framework and partnerships.

Exploring the Historic Journey to the WIPO Treaty on Genetic Resources

Update A Historic Achievement: The Adoption of the WIPO Treaty On May 24, 2024, a remarkable milestone was reached in international law — the World Intellectual Property Organization (WIPO) adopted the Treaty on Intellectual Property, Genetic Resources and Associated Traditional Knowledge. This moment marked 25 years of deliberation, advocacy, and negotiation primarily driven by developing countries and Indigenous Peoples who have long sought greater protection for their traditional knowledge and genetic resources. The Journey: Decades of Advocacy From the initial proposal for a new patent disclosure requirement in 1999, numerous discussions culminated in this groundbreaking Treaty. The journey involved dedicated advocates from developing nations pushing against formidable opposition, particularly from industrialized countries. The commitment to changing the global patent landscape is underpinned by grassroots campaigns and a drive for social justice, illustrating the deep-rooted commitment to protecting Indigenous wisdom. The Patent System Under Pressure The new Treaty imposes additional obligations on patent applicants to disclose the origins of genetic resources they use. Critics, such as those from the United States and Japan, argue that this could compromise the efficiency and attractiveness of the patent system. Laura Peter, a former U.S. Patent and Trademark Office director, warns that adding unrelated requirements to patent applications could distort the foundational balance intended by patent law, thereby stifling innovation. Counterarguments: The Call for Fairer Benefits While some see the Treaty as an unwelcome complexity within the patent system, proponents believe it is a necessary step towards rectifying historical injustices related to biopiracy. By ensuring equitable benefit-sharing, the Treaty aims to empower Indigenous communities and safeguard biodiversity. The arguments for and against the Treaty underscore the complexity of reconciling intellectual property rights with social equity. Future Implications: A Path Toward Greater Equity? As the Treaty has not yet come into force, its future impact remains uncertain. Countries must ratify the agreement for it to be fully operational. What lies ahead is a crucial phase where policymakers and stakeholders in the patent system will have to navigate the challenges and opportunities for implementing this Treaty. The emphasis is on making sure that the aspirations expressed in the Treaty translate into real, measurable outcomes for Indigenous Peoples and biodiversity conservation. The WIPO Treaty is not a simple blueprint for change; it represents a shift in how knowledge and innovation are perceived and respected. By placing Indigenous knowledge at the center of this discourse, the Treaty stands to be far more than just a legal document; it embodies a renewed commitment to creating a just and equitable world. Policymakers, scholars, and advocacy groups must now come together to transform the Treaty’s promise into tangible actions. The narrative around intellectual property needs to evolve, and the story of the WIPO Treaty could well serve as a case study for effective global collaboration on complex issues that intertwine science, law, and community.

Bye-Bye 280E: How Cannabis Rescheduling Will Transform the Industry

Update Historic Executive Order Signals a New Era for Cannabis On December 18, 2025, a landmark moment in U.S. cannabis legislation occurred with President Trump’s signing of an executive order aimed at rescheduling marijuana from Schedule I to Schedule III under the Controlled Substances Act (CSA). This significant shift is not just a bureaucratic change; it carries profound implications for the cannabis industry, particularly concerning taxation and operational viability. The Immediate Impact on Cannabis Taxation A critical outcome of this rescheduling involves the groundbreaking elimination of Section 280E of the Internal Revenue Code. Currently, this section prohibits businesses dealing in Schedule I substances from deducting ordinary business expenses, which has significantly hindered the economic potential of cannabis operators. For years, cannabis businesses have been subjected to effective tax rates that can exceed 70%, primarily due to their inability to deduct common operating expenses such as rent, employee wages, and utilities. Imagine a cannabis business generating $1,000,000 in revenue yet ending up with negative cash flow due to tax burdens stemming from Section 280E. Traditional businesses, by contrast, face a mere fraction of these challenges—creating a stark disadvantage in the marketplace. By classifying cannabis as a Schedule III substance, operators will finally be able to reclaim deductions that can significantly improve their bottom lines and cash flow. Transforming Access to Financial Resources Beyond taxation, this new directive is poised to improve the broader financial ecosystem for cannabis enterprises. Previously, financial institutions have been reluctant to engage with cannabis companies, largely due to the stringent regulations surrounding Schedule I classifications. With the rescheduling, banks and insurers may find renewed confidence to enter the market, enabling cannabis businesses to access loans, investment capital, and insurance products previously deemed too risky. “We view today’s announcement as a true inflection point for the US cannabis industry,” stated Karan Wadera of Casa Verde Capital. He highlighted the potential for this rescheduling to reshape cash flows, balance sheets, and valuation frameworks overnight, ushering in an era of greater financial backing for cannabis operators. Acknowledging Medical Use: A Shift in Perspective Another significant aspect of this executive order is the federal acknowledgment of cannabis's medical utility. This legislation recognizes that over 30,000 licensed healthcare professionals have sanctioned the use of medical marijuana to benefit more than 6 million patients, particularly for conditions like chronic pain and anxiety. This shift not only strengthens the foundation for existing state medical marijuana programs but also opens discussions around potential health insurance coverage for medical cannabis. Preparing for the Future: Strategic Steps for Cannabis Businesses While the rescheduled classification has yet to take immediate effect, cannabis operators should proactively prepare for the upcoming changes. Engaging tax advisors to outline a plan for post-280E operations can lay the groundwork for future benefits. Businesses should assess their operational structures, explore potential mergers and acquisitions, and prepare for an influx of investment as financial markets adjust. Documentation of past expenditures will also become crucial in leveraging new tax deductions. As we look ahead, cannabis stakeholders must remain vigilant in monitoring the status of this executive order and its implications for policy at both federal and state levels. Ensuring your business is adaptable and informed could place you at the forefront of an exponentially expanding industry. With these developments on the horizon, it’s time for cannabis entrepreneurs to gear up for a transformative shift in the landscape of cannabis rescheduling. This is a pivotal moment that could finally usher in the operational freedom many have long sought in the cannabis sector.

Terms of Service

Privacy Policy

Core Modal Title

Sorry, no results found

You Might Find These Articles Interesting

T
Please Check Your Email
We Will Be Following Up Shortly
*
*
*